Navigation Links
Immtech Reports Fiscal First Quarter 2009 Results
Date:8/11/2008

focused on the development and commercialization of new drugs to treat infectious diseases. Immtech has a well defined, expanding library of compounds targeting Hepatitis C, drug-resistant Gram-positive bacteria, fungal infections and other serious diseases. It is expanding its targeted markets by applying its proprietary pharmaceutical platform to treat a range of disorders. Immtech holds exclusive worldwide licenses to certain patents, patent applications and technology for products derived from its proprietary pharmaceutical platform. For additional information, please visit the Company's website at http://www.immtechpharma.com

"Safe Harbor" Statement under the Private Securities Reform Act of 1995: Statements in this press release regarding Immtech Pharmaceuticals, Inc.'s business which are not historical facts are "forward-looking statements" that involve risks and uncertainties. Actual results could differ materially from these forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed under the headings "Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Risk Factors" in Immtech's annual report on Form 10-K for the fiscal year ended March 31, 2008 filed with the SEC on June 18, 2008, and in its other SEC filings and include, but are not limited to: (i) Immtech's ability to obtain additional funds; (ii) Immtech's ability to manage its remaining resources; (iii) Immtech's ability to continue as a going concern; (iv) Immtech's ability to retain key personnel; (v) the ability of Immtech's scientists and collaborators to discover new compounds; (vi) the availability of additional research grants; (vii) Immtech's ability to obtain regulatory approval of its drugs candidates; (viii) the success of Immtech's clinical trials; (ix) dependence upon and contractual relationship with partners
'/>"/>

SOURCE Immtech Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Immtech Pharmaceuticals and Beijing Capital Medical University Announce Joint Venture to Provide Contract Research Services in China
2. Immtech Appoints Blythe Weigh as Strategic Advisor
3. Immtech Reports Fiscal Third Quarter 2008 Results
4. Immtech Investor Conference Call Scheduled for February 11, 2008
5. Immtech and BioAlliance Sign Licensing Agreement for Pafuramidine
6. Immtech to Present at The Bank of Montreal Healthcare Conference
7. ULURU Inc. Reports Second Quarter 2008 Financial Results
8. BMP Sunstone Reports Second Quarter 2008 Financial Results
9. MGT Capital Investments Reports Second Quarter 2008 Financial Results and Provides Update on Recent Developments
10. Halozyme Therapeutics Reports 2008 Second Quarter Financial Results
11. Pharmos Corporation Reports 2008 Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... Calcivis, a medical devices ... decay, today announces that it has completed a ... Imaging System. The Calcivis Caries Activity ... consumable combination designed to transform the assessment and ... a unique, proprietary bioluminescence approach combined with a ...
(Date:11/26/2014)... 2014 The North America Thermal ... market for detailed analysis of the growth trends ... reach $616.3 million by 2018, growing at a ... Browse through the TOC of the North America ... idea of the in-depth analysis and industry segmentation ...
(Date:11/26/2014)... (PRWEB) November 26, 2014 On January, ... the Baltimore and Washington D.C. science community to the ... The event, sponsored by the Protein Society, will take ... University Center, Room 312. Through discussion, presentations and ... structural importance of proteins, their role in the industry ...
(Date:11/26/2014)... CA (PRWEB) November 25, 2014 Silicon ... joins forces with RPM Alliance , provider of ... pharmaceutical companies. With the latest addition to its CRO ... free validated EDC system to India. , “We ... a robust and customizable EDC platform which is both ...
Breaking Biology Technology:Calcivis Completes Clinical Study of Novel Caries Activity Imaging System 2Calcivis Completes Clinical Study of Novel Caries Activity Imaging System 3The North America Thermal Protective Clothing Market is estimated to grow up to $616.3 million by 2018 - Report by MicroMarket Monitor 2The North America Thermal Protective Clothing Market is estimated to grow up to $616.3 million by 2018 - Report by MicroMarket Monitor 3RPM Alliance Joins Clinovo’s CRO Partnership Program, Further Strengthening Its Presence in Southern California and India 2
... Mass., March 11 Boston Scientific,Corporation (NYSE: BSX ... Care Conference, which is being held March 18 - ... will make a 25-minute,presentation on Tuesday, March 18, beginning ... and Chief Financial Officer will,join Mr. LaViolette in a ...
... Advisory Board Programs Exemplify, Why Halogen ... Market, OTTAWA, March 11 /PRNewswire/ - Halogen ... and talent management software,announced today that its customers ... and challenges and play a critical role in ...
... TORONTO and MONTREAL, March 11 /PRNewswire/ - GreenField ... gasification and,catalysis technology company, have signed a Binding ... on a commercial scale., "We are excited ... a,commercial reality in Canada," said Bob Gallant, President ...
Cached Biology Technology:Halogen Customers Shape Industry-Leading Employee Performance and Talent Management Solution 2Halogen Customers Shape Industry-Leading Employee Performance and Talent Management Solution 3GreenField Ethanol and Enerkem Announce Plans to Make Cellulosic Ethanol a Commercial Reality 2GreenField Ethanol and Enerkem Announce Plans to Make Cellulosic Ethanol a Commercial Reality 3
(Date:11/18/2014)... , Nov. 18, 2014   EyeLock Inc. ... solutions, and MorphoTrust USA (Safran), a ... today announced a strategic partnership to offer comprehensive ... vehicle administration (MVA), airport screening and financial services ... solutions, MorphoTrust serves consumers through a nationwide network ...
(Date:11/11/2014)... , Nov. 11, 2014  Forensicon, Inc., a ... firm, is pleased to announce the promotion of ... Director of Digital Forensics. In Schiff,s new role as ... the team of digital forensics examiners and provide leadership ... Photo - http://photos.prnewswire.com/prnh/20141110/157719 ...
(Date:11/7/2014)... Calif. , Nov. 7, 2014  In conjunction with ... Police Departments, The Community Foundation of the Verdugos ... DNA JUSTICE PROJECT," a $250,000 initiative to keep ... initial phase. In its first six months of existence, the ... needed evidence support for local law enforcement. "Because ...
Breaking Biology News(10 mins):EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3Yaniv Schiff Promoted to Director of Digital Forensics at Forensicon, Inc. 2Community Foundation Of The Verdugos Unveils Campaign To Fund Glendale-Burbank DNA Justice Project 2
... A paleontological team that includes scientists from the American ... and Case Western Reserve University has described two ancient ... a discovery that substantiates what might be the earliest ... near a chain of volcanoes about 32.5 million years ...
... new and powerful class of antioxidants could one day be ... class of antioxidants called synthetic triterpenoids blocked development of Parkinson,s ... handful of days, said Dr. Bobby Thomas, neuroscientist at the ... corresponding author of the study in the journal Antioxidants ...
... July 23, 2012 Scientists have embarked on a 3-week ... Mexico to understand how surface ocean currents near the site ... oil/dispersants, like those from the 2010 spill. In other words, ... get there. This experiment is an essential step in understanding ...
Cached Biology News:New species of ancient rodents hint at what could be world's oldest grasslands 2New species of ancient rodents hint at what could be world's oldest grasslands 3Powerful class of antioxidants may be potent Parkinson's treatment 2The largest research expedition of its kind near the site of Deepwater Horizon incident 2The largest research expedition of its kind near the site of Deepwater Horizon incident 3
...
Human PDGF R beta MAb (Clone # PR7212)...
Zebrafish Ephrin-B2 Biotinylated Affinity Purified PAb...
Collected from 8-12 week old New Zealand or Californian rabbits. Aseptically collected and processed to minimize hemolytic activity. Pricing: $60/unit for 1 - 10 units...
Biology Products: